Topic List : Infectious Disease
Bloodstream pathogens often come from gut
A computational tool designed by Stanford scientists makes it easier to identify the source of bloodstream infections and, ideally, rid patients of reservoirs where potentially troublesome microbes reside.
Decision scientist seeks hepatitis B solutions
Mehlika Toy merged her interests in infectious diseases and mathematics to forge a career in decision science. She builds models to estimate the impact of clinical interventions to inform health policy.
Technique for quickly spotting TB
A newly created two-piece fluorescent probe gets activated when it comes in contact with tuberculosis bacteria in a phlegm.
Biomarker for flu susceptibility discovered
Scientists at Stanford are believed to be the first to have discovered a biomarker that can predict who will be most susceptible to influenza.
Conference on human immune monitoring
The two-day event will highlight the latest research by top scientists on technologies and analytic methods geared toward studying human immunology.
Drug blocks several mosquito-borne viruses
A new Stanford study details how to shut off proteins in mammalian cells to keep viruses such as Zika, dengue and West Nile from replicating in them.
High cost of fewer measles vaccinations
A 5 percent drop in childhood measles vaccination levels would cause annual measles cases to triple, according to researchers at Stanford and Baylor.
Preventing HIV among drug users
As more people inject drugs like heroin, the risk of an HIV outbreak from shared needles increases. Stanford researchers examined four methods that could be cost-effective in preventing an outbreak.
Samuel So on ending viral hepatitis
A Stanford liver disease expert and leading anti-hepatitis campaigner recently discussed what it will take to rub out viral hepatitis and why it’s important. Hint: It causes more than 20,000 U.S. deaths annually.
Drug combo effective against dengue, Ebola
To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.